Qinghai Spring Medicinal Resources Technology Co Ltd Working Capital to Net Assets Ratio
Qinghai Spring Medicinal Resources Technology Co Ltd working capital to net assets ratio. Qinghai Spring Medicinal Resources Technology Co Ltd (600381) has a Working Capital to Net Assets ratio of 60.6% as of March 2026. Working capital of CN¥596.19 Million (current assets of CN¥631.97 Million minus current liabilities of CN¥35.78 Million) is measured against net assets of CN¥983.66 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. Check tangible equity quality of Qinghai Spring Medicinal Resources Techn to evaluate the tangible quality of the company's equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Working Capital to Net Assets Ratio of Qinghai Spring Medicinal Resources Technology Co Ltd (1998–2025)
Working capital to net assets ratio of Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025. This chart shows how Qinghai Spring Medicinal Resources Technology Co Ltd's Working Capital to Net Assets ratio has evolved across 28 annual periods from 1998 to 2025. As of March 2026, the ratio stands at 60.6%, reflecting working capital of CN¥596.19 Million against net assets of CN¥983.66 Million CNY. See Qinghai Spring Medicinal Resources Techn defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Qinghai Spring Medicinal Resources Technology Co Ltd Working Capital to Net Assets Ratio by Year (1998–2025)
Qinghai Spring Medicinal Resources Technology Co Ltd working capital to net assets ratio by year from 1998 to 2025. The table below presents the year-by-year Working Capital to Net Assets ratio for Qinghai Spring Medicinal Resources Technology Co Ltd from 1998 to 2025, covering 28 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Qinghai Spring Medicinal Resources Techn asset portfolio.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 60.7% | CN¥607.18 Million | CN¥999.61 Million | CN¥651.30 Million | CN¥44.12 Million | ▲ +13.1 pp |
| 2024 | 47.6% | CN¥493.61 Million | CN¥1.04 Billion | CN¥618.15 Million | CN¥124.55 Million | ▼ -5.1 pp |
| 2023 | 52.7% | CN¥668.09 Million | CN¥1.27 Billion | CN¥749.24 Million | CN¥81.14 Million | ▲ +0.9 pp |
| 2022 | 51.8% | CN¥794.28 Million | CN¥1.53 Billion | CN¥816.00 Million | CN¥21.73 Million | ▼ -1.5 pp |
| 2021 | 53.3% | CN¥969.75 Million | CN¥1.82 Billion | CN¥994.46 Million | CN¥24.70 Million | ▼ -0.3 pp |
| 2020 | 53.6% | CN¥1.11 Billion | CN¥2.07 Billion | CN¥1.24 Billion | CN¥133.99 Million | ▲ +2.1 pp |
| 2019 | 51.5% | CN¥1.23 Billion | CN¥2.39 Billion | CN¥1.25 Billion | CN¥15.44 Million | ▼ -17.1 pp |
| 2018 | 68.6% | CN¥1.63 Billion | CN¥2.38 Billion | CN¥1.66 Billion | CN¥30.54 Million | ▼ -7.9 pp |
| 2017 | 76.4% | CN¥1.77 Billion | CN¥2.32 Billion | CN¥1.81 Billion | CN¥41.74 Million | ▼ -11.7 pp |
| 2016 | 88.1% | CN¥1.77 Billion | CN¥2.00 Billion | CN¥1.85 Billion | CN¥79.31 Million | ▼ -1.8 pp |
| 2015 | 89.9% | CN¥1.58 Billion | CN¥1.76 Billion | CN¥1.76 Billion | CN¥179.64 Million | ▲ +16.0 pp |
| 2014 | 73.9% | CN¥227.94 Million | CN¥308.44 Million | CN¥529.16 Million | CN¥301.22 Million | ▼ -47.2 pp |
| 2013 | 121.1% | CN¥60.59 Million | CN¥50.03 Million | CN¥672.33 Million | CN¥611.74 Million | ▲ +98.3 pp |
| 2012 | 22.8% | CN¥490.33 Million | CN¥2.15 Billion | CN¥1.94 Billion | CN¥1.45 Billion | ▼ -25.4 pp |
| 2011 | 48.2% | CN¥1.12 Billion | CN¥2.32 Billion | CN¥1.97 Billion | CN¥851.71 Million | ▼ -377.7 pp |
| 2010 | 425.9% | CN¥-494.51 Million | CN¥-116.10 Million | CN¥64.06 Million | CN¥558.58 Million | ▲ +191.3 pp |
| 2009 | 234.6% | CN¥-417.87 Million | CN¥-178.12 Million | CN¥48.10 Million | CN¥465.96 Million | ▲ +65.0 pp |
| 2008 | 169.6% | CN¥-391.40 Million | CN¥-230.81 Million | CN¥43.33 Million | CN¥434.73 Million | ▲ +128.7 pp |
| 2007 | 40.9% | CN¥-148.09 Million | CN¥-362.40 Million | CN¥282.83 Million | CN¥430.92 Million | ▼ -83.3 pp |
| 2006 | 124.2% | CN¥-533.58 Million | CN¥-429.60 Million | CN¥329.20 Million | CN¥862.79 Million | ▲ +20.4 pp |
| 2005 | 103.8% | CN¥340.14 Million | CN¥327.77 Million | CN¥1.23 Billion | CN¥885.33 Million | ▼ -53.5 pp |
| 2004 | 157.3% | CN¥770.38 Million | CN¥489.71 Million | CN¥1.42 Billion | CN¥648.42 Million | ▲ +114.2 pp |
| 2003 | 43.1% | CN¥168.76 Million | CN¥391.64 Million | CN¥721.18 Million | CN¥552.42 Million | ▲ +20.9 pp |
| 2002 | 22.1% | CN¥77.92 Million | CN¥351.79 Million | CN¥474.15 Million | CN¥396.24 Million | ▼ -32.1 pp |
| 2001 | 54.2% | CN¥181.04 Million | CN¥333.98 Million | CN¥445.99 Million | CN¥264.94 Million | ▲ +50.6 pp |
| 2000 | 3.6% | CN¥4.21 Million | CN¥117.80 Million | CN¥189.12 Million | CN¥184.91 Million | ▼ -26.3 pp |
| 1999 | 29.9% | CN¥33.92 Million | CN¥113.38 Million | CN¥161.97 Million | CN¥128.04 Million | ▼ -24.0 pp |
| 1998 | 53.9% | CN¥50.60 Million | CN¥93.87 Million | CN¥170.09 Million | CN¥119.48 Million | — |